We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » BIO & PhRMA Warn of Bad Hatch-Waxman Precedent in Patent Case on Suprep
BIO & PhRMA Warn of Bad Hatch-Waxman Precedent in Patent Case on Suprep
A federal appeals court needs to rethink its definition of “a patient” or risk upholding a dangerous precedent in future Hatch-Waxman cases, trade groups BIO and PhRMA argued after a recent patent ruling on the colon cleanser Suprep.